US2008132964A1PendingUtilityA1
Selective nerve fiber stimulation for treating heart conditions
Est. expiryJan 23, 2022(expired)· nominal 20-yr term from priority
A61B 5/024A61B 5/4041A61N 1/36114A61N 1/3627A61B 5/412A61N 1/3621A61N 1/0551A61B 5/7217A61B 5/4029A61N 1/0556
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Apparatus is provided that includes an electrode device, adapted to be coupled to a vagus nerve of a subject, and a control unit, adapted to drive the electrode device to apply to the vagus nerve a current that reduces heart rate variability of the subject. Also provided is a method comprising applying to a vagus nerve of a subject a current that reduces heart rate variability of the subject.
Claims
exact text as granted — not AI-modified1 - 80 . (canceled)
81 . A method for treating a subject, comprising:
identifying that the subject suffers from a condition selected from the group consisting of: atrial arrhythmia, and atrial arrhythmia combined with heart failure; and treating the condition by: driving, by a control unit, application of a current to a site of the subject selected from the group consisting of: a vagus nerve and an epicardial fat pad, configuring the current so as to treat the condition, and driving an implantable cardioverter defibrillator (ICD) to apply energy to a heart of the subject, the ICD being in communication with the control unit that drives the application of the current.
82 . A method for treating a subject, comprising:
identifying that the subject suffers from atrial arrhythmia; and treating the atrial arrhythmia by:
applying a current to a site of the subject selected from the group consisting of: a vagus nerve and an epicardial fat pad, and
configuring the current to control a heart rate during atrial arrhythmia.
83 . The method according to claim 82 , wherein applying the current comprises synchronizing the application of the current with a cardiac cycle of the subject.
84 . The method according to claim 82 , comprising driving an implantable cardioverter defibrillator (ICD) to apply energy to a heart of the subject, the ICD being in communication with a control unit that drives the application of the current.
85 . The method according to claim 82 , comprising driving an implantable pacemaker to apply energy to a heart of the subject, the pacemaker being in communication with a control unit that drives the application of the current.
86 . The method according to claim 82 , wherein identifying comprises identifying that the subject suffers from the atrial arrhythmia combined with heart failure, and wherein treating comprises treating the atrial arrhythmia combined with the heart failure.
87 . A treatment method, comprising:
identifying that a subject suffers from a heart condition; and treating the heart condition by: applying a current to a vagus nerve of the subject, and configuring the current to increase coronary blood flow.
88 . The method according to claim 87 , wherein the heart condition includes variant angina, and wherein identifying comprises identifying that the subject suffers from the variant angina.
89 . The method according to claim 87 , wherein applying the current comprises receiving an override signal generated by the subject, and applying the current responsively to the override signal.
90 . Apparatus comprising:
an electrode device, configured to be coupled to a vagus nerve of the subject; and a control unit, configured to: receive a subject-generated override signal indicative of variant angina, and responsively to the override signal, apply a current to the vagus nerve, and to configure the current to treat the variant angina.
91 . The apparatus according to claim 90 , and comprising an external magnet, wherein the control unit is configured to receive the subject-generated override signal generated using the external magnet.
92 . The apparatus according to claim 90 , wherein the control unit is configured to configure the current to increase coronary blood flow, so as to treat the variant angina.
93 . A treatment method comprising:
identifying that a subject suffers from a variant angina; and treating the variant angina by applying a current to a vagus nerve of the subject responsively to receiving an override signal from the subject.
94 . The method according to claim 93 , wherein treating the variant angina comprises configuring the current to increase coronary blood flow.
95 . The method according to claim 93 , wherein receiving the override signal comprises receiving the override signal generated by the subject using an external magnet.Join the waitlist — get patent alerts
Track US2008132964A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.